S&P 5007,683.69▼0.8% Nasdaq26,820.38▼0.9% Dow51,481.51▼0.7% Russell 2K2,817.91▼0.7% 10-Yr5.24%+6bp VIX16.07+1.20 WTI$93.42▲1.1% Gold$4,147.50▼4.0% EUR/USD1.137▼0.1% BTC$83,817▲0.2% Nikkei65,339▼1.6%
At close · Tue, Sep 29, 2026
Daily Market Updates.

Global Markets

Home›Global Markets›Europe›Real-world data shows weight loss after switching to W…

Real-world data shows weight loss after switching to Wegovy pill

The study suggests some patients may be able to move from injection to a more convenient option without losing momentum.

Reported · Written up by our desk · Europe

CNBC Markets reports that real-world data on Novo Nordisk’s Wegovy pill found that people who switched from obesity injections continued to lose weight.

CNBC World similarly said the findings indicate patients may not need to take weekly injections forever, and could instead choose a more convenient treatment approach.

← Newer storyUS-led coalition ends Iraq mission, troops to leave most bases

More like this

Global MarketsUK GDP growth revised to 0.5% for April to June
Global MarketsEuropean leaders urge major cuts to fund proposed 2 trillion euro defense budget
Global MarketsWealth of UK energy and food magnates rose as essentials costs climbed
Global MarketsRussia steps up attacks on Kyiv data centers and communications infrastructure
Global MarketsCrude-linked Indian stocks rise as oil prices fall

Sources

CNBC MarketsPeople switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study
CNBC WorldPeople switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.